Assignee
INVENTISBIO CO LTD
CN·16 granted patents·17 pending applications·5 citations·filing 2019–2025
Top patents by PatentIndex Score
33 records- 0197US11091481B2Heterocyclic compounds, preparation and methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Aug 17, 2021·5 cites·10 claims
- 0283US12246020B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0382US2024208967A1Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses ThereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 0479US11498921B1Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Nov 15, 2022·0 cites·4 claims
- 0579US2024165088A1Novel salts of selective estrogen receptor degradersINVENTISBIO CO LTD·Filed 2024·Application pending·0 cites
- 0677US11903931B2Salts of selective estrogen receptor degradersINVENTISBIO CO LTD·Filed 2022·Granted Feb 20, 2024·0 cites·12 claims
- 0777US2025313545A1Heteroaryl compounds, solid forms, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 0875US11685720B2Salt forms of URAT-1 inhibitorsINVENTISBIO CO LTD·Filed 2022·Granted Jun 27, 2023·0 cites·19 claims
- 0974US11865115B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Granted Jan 9, 2024·0 cites·3 claims
- 1073US2021261543A1Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 1172US2024025876A1Heteroaryl compounds, solid forms, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 1271US12391677B2Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·10 claims
- 1370US12173010B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 1470US11241437B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Feb 8, 2022·0 cites·23 claims
- 1569US12492184B2Heteroaryl compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Dec 9, 2025·0 cites·2 claims
- 1669US12227491B2EGFR inhibitorsINVENTISBIO CO LTD·Filed 2023·Granted Feb 18, 2025·0 cites·20 claims
- 1769US2025340542A1Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 1867US11639344B2EGFR inhibitorsINVENTISBIO CO LTD·Filed 2019·Granted May 2, 2023·0 cites·9 claims
- 1961US12110289B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Oct 8, 2024·0 cites·17 claims
- 2060US2025223301A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 2160US2025263394A1Compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 2259US2024189313A1Solid dispersionsINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 2358US11691981B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2020·Granted Jul 4, 2023·0 cites·21 claims
- 2457US2024343727A1Pyridazinone or pyridinone compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 2556US2025195475A1Cdk2 inhibitor and preparation method and use thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 2655US12509448B2Salts of indoleamine 2,3-dioxygenase inhibitorsINVENTISBIO CO LTD·Filed 2020·Granted Dec 30, 2025·0 cites·12 claims
- 2755US2025215014A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 2855US2023263782A1Oral formulations and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 2952US2023357233A1Heteroaryl compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 3051US2023242544A1Quinazoline compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 3151US2023339911A1Pyridazinone compoundsINVENTISBIO CO LTD·Filed 2020·Application pending·0 cites
- 3250US2022213066A1Salts of a class of pyrimidine compounds, polymorphs, and pharmaceutical compositions thereof, preapration methods therefor and uses thereofINVENTISBIO CO LTD·Filed 2020·Application pending·0 cites
- 3348US12427146B2C-terminal SRC kinase inhibitorsINVENTISBIO CO LTD·Filed 2019·Granted Sep 30, 2025·0 cites·38 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →